Featured research - TAVI - Part 4

Summary

This session addresses contemporary challenges in TAVI, including management of acute valve syndrome through service innovations and the application of Valvosoft non-invasive ultrasound therapy in severe aortic stenosis. It also explores complications such as infective endocarditis post-TAVI, evaluates the feasibility of same-day discharge protocols, and assesses the safety and efficacy of TAVI in patients with bicuspid aortic valve stenosis.

Presentations available when logged in:

  • Addressing acute valve syndrome presentations in an Australian TAVI programme using service innovation
  • Valvosoft non-invasive ultrasound therapy in very severe aortic stenosis: 12-month results
  • Infective endocarditis after TAVI
  • Is same-day discharge of TAVI patients possible?
  • Safety and efficacy of TAVI in bicuspid aortic valve stenosis